VU6015241 

VU6015241 is a selective, blood-brain barrier-permeable M4 mAChR Antagonist with a K_i value of 43.3 nM. VU6015241 is used for the research of dystonia and related movement disorders^[1].

VU6015241 potently inhibits acetylcholine-stimulated calcium mobilization in hM₄/Gqi5-CHO cells with an IC₅₀ of 71 nM^[1].
VU6015241 inhibits acetylcholine-stimulated calcium mobilization in rM₄-CHO cells with an IC₅₀ of 44 nM^[1].
VU6015241 is highly selective for human and rat M₄ receptors, with IC₅₀ values >10,000 nM at hM₁, hM₂, rM₁, rM₂, rM₃, and rM₅ receptors expressed in CHO cells^[1].
VU6015241 has a predicted low rat hepatic clearance of 6.2 mL/min/kg^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

VU6015241 (3-30 mg/kg; i.v., i.p.; single dose) administered intravenously at 3 mg/kg to rats shows high plasma clearance of 257 mL/min/kg and a long elimination half-life of 8.6 h, while intraperitoneal administration at 30 mg/kg results in moderate brain exposure with a K_p of 0.23^[1].
VU6015241 (30 mg/kg; i.p.; single dose) administered intraperitoneally at 30 mg/kg to mice results in moderate brain exposure with a K_p of 0.38, which is higher than the brain exposure observed in rats at the same dose and route^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

449.59

C₂₆H₃₅N₅O₂

2264025-00-3

CC(NC(C=C1)=CC=C1C(N=N2)=CC=C2NC[C@H]3C4(CCN(CC4)CC5CCOCC5)C3)=O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Bender AM, et al. Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M₄ muscarinic acetylcholine receptor. Bioorg Med Chem Lett. 2022;56:128479.